Literature DB >> 25917055

Toward a complete dataset of drug-drug interaction information from publicly available sources.

Serkan Ayvaz1, John Horn2, Oktie Hassanzadeh3, Qian Zhu4, Johann Stan5, Nicholas P Tatonetti6, Santiago Vilar7, Mathias Brochhausen8, Matthias Samwald9, Majid Rastegar-Mojarad10, Michel Dumontier11, Richard D Boyce12.   

Abstract

Although potential drug-drug interactions (PDDIs) are a significant source of preventable drug-related harm, there is currently no single complete source of PDDI information. In the current study, all publically available sources of PDDI information that could be identified using a comprehensive and broad search were combined into a single dataset. The combined dataset merged fourteen different sources including 5 clinically-oriented information sources, 4 Natural Language Processing (NLP) Corpora, and 5 Bioinformatics/Pharmacovigilance information sources. As a comprehensive PDDI source, the merged dataset might benefit the pharmacovigilance text mining community by making it possible to compare the representativeness of NLP corpora for PDDI text extraction tasks, and specifying elements that can be useful for future PDDI extraction purposes. An analysis of the overlap between and across the data sources showed that there was little overlap. Even comprehensive PDDI lists such as DrugBank, KEGG, and the NDF-RT had less than 50% overlap with each other. Moreover, all of the comprehensive lists had incomplete coverage of two data sources that focus on PDDIs of interest in most clinical settings. Based on this information, we think that systems that provide access to the comprehensive lists, such as APIs into RxNorm, should be careful to inform users that the lists may be incomplete with respect to PDDIs that drug experts suggest clinicians be aware of. In spite of the low degree of overlap, several dozen cases were identified where PDDI information provided in drug product labeling might be augmented by the merged dataset. Moreover, the combined dataset was also shown to improve the performance of an existing PDDI NLP pipeline and a recently published PDDI pharmacovigilance protocol. Future work will focus on improvement of the methods for mapping between PDDI information sources, identifying methods to improve the use of the merged dataset in PDDI NLP algorithms, integrating high-quality PDDI information from the merged dataset into Wikidata, and making the combined dataset accessible as Semantic Web Linked Data.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug–drug interaction; Natural language processing; Pharmacovigilance; Record linkage

Mesh:

Year:  2015        PMID: 25917055      PMCID: PMC4464899          DOI: 10.1016/j.jbi.2015.04.006

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  34 in total

1.  Proposal for a new tool to evaluate drug interaction cases.

Authors:  John R Horn; Philip D Hansten; Lingtak-Neander Chan
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

2.  Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records.

Authors:  Shobha Phansalkar; Heleen van der Sijs; Alisha D Tucker; Amrita A Desai; Douglas S Bell; Jonathan M Teich; Blackford Middleton; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2012-09-25       Impact factor: 4.497

3.  Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.

Authors:  Lorraine M Wang; Maple Wong; James M Lightwood; Christine M Cheng
Journal:  Ann Pharmacother       Date:  2009-12-29       Impact factor: 3.154

4.  Data-driven prediction of drug effects and interactions.

Authors:  Nicholas P Tatonetti; Patrick P Ye; Roxana Daneshjou; Russ B Altman
Journal:  Sci Transl Med       Date:  2012-03-14       Impact factor: 17.956

5.  Similarity-based modeling in large-scale prediction of drug-drug interactions.

Authors:  Santiago Vilar; Eugenio Uriarte; Lourdes Santana; Tal Lorberbaum; George Hripcsak; Carol Friedman; Nicholas P Tatonetti
Journal:  Nat Protoc       Date:  2014-08-14       Impact factor: 13.491

6.  Performance of community pharmacy drug interaction software.

Authors:  T K Hazlet; T A Lee; P D Hansten; J R Horn
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

7.  Computing with evidence Part II: An evidential approach to predicting metabolic drug-drug interactions.

Authors:  Richard Boyce; Carol Collins; John Horn; Ira Kalet
Journal:  J Biomed Inform       Date:  2009-06-16       Impact factor: 6.317

8.  Pharmacointeraction network models predict unknown drug-drug interactions.

Authors:  Aurel Cami; Shannon Manzi; Alana Arnold; Ben Y Reis
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

9.  The SADI Personal Health Lens: A Web Browser-Based System for Identifying Personally Relevant Drug Interactions.

Authors:  Ben Vandervalk; E Luke McCarthy; José Cruz-Toledo; Artjom Klein; Christopher J O Baker; Michel Dumontier; Mark D Wilkinson
Journal:  JMIR Res Protoc       Date:  2013-04-05

10.  Extending the "web of drug identity" with knowledge extracted from United States product labels.

Authors:  Oktie Hassanzadeh; Qian Zhu; Robert Freimuth; Richard Boyce
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2013-03-18
View more
  37 in total

1.  Data-Driven Prediction of Beneficial Drug Combinations in Spontaneous Reporting Systems.

Authors:  Ying Li; Ping Zhang; Zhaonan Sun; Jianying Hu
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

Review 2.  Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.

Authors:  Yuan Luo; William K Thompson; Timothy M Herr; Zexian Zeng; Mark A Berendsen; Siddhartha R Jonnalagadda; Matthew B Carson; Justin Starren
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

3.  Generalizing biomedical relation classification with neural adversarial domain adaptation.

Authors:  Anthony Rios; Ramakanth Kavuluru; Zhiyong Lu
Journal:  Bioinformatics       Date:  2018-09-01       Impact factor: 6.937

Review 4.  Effect of Educating the Primary Care Physician About Headache to Help Reduce "Trivial" Referrals and Improve the Number and Quality of "Substantial" Referrals that Truly Need Subspecialty Headache Medicine Care.

Authors:  Robert Cowan; Meredith Barad
Journal:  Curr Treat Options Neurol       Date:  2017-07       Impact factor: 3.598

Review 5.  Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis.

Authors:  Mary Grace Fitzmaurice; Adrian Wong; Hannah Akerberg; Simona Avramovska; Pamela L Smithburger; Mitchell S Buckley; Sandra L Kane-Gill
Journal:  Drug Saf       Date:  2019-09       Impact factor: 5.606

6.  Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support.

Authors:  Kin Wah Fung; Joan Kapusnik-Uner; Jean Cunningham; Stefanie Higby-Baker; Olivier Bodenreider
Journal:  J Am Med Inform Assoc       Date:  2017-07-01       Impact factor: 4.497

7.  Drug-drug interaction discovery and demystification using Semantic Web technologies.

Authors:  Adeeb Noor; Abdullah Assiri; Serkan Ayvaz; Connor Clark; Michel Dumontier
Journal:  J Am Med Inform Assoc       Date:  2017-05-01       Impact factor: 4.497

8.  Advancement in predicting interactions between drugs used to treat psoriasis and its comorbidities by integrating molecular and clinical resources.

Authors:  Matthew T Patrick; Redina Bardhi; Kalpana Raja; Kevin He; Lam C Tsoi
Journal:  J Am Med Inform Assoc       Date:  2021-06-12       Impact factor: 4.497

9.  Testing the face validity and inter-rater agreement of a simple approach to drug-drug interaction evidence assessment.

Authors:  Amy J Grizzle; Lisa E Hines; Daniel C Malone; Olga Kravchenko; Harry Hochheiser; Richard D Boyce
Journal:  J Biomed Inform       Date:  2019-12-12       Impact factor: 6.317

10.  Potential drug-drug interactions among hospitalized patients in a developing country.

Authors:  Sarah Mousavi; Golshan Ghanbari
Journal:  Caspian J Intern Med       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.